140410 - Mezzion Pharma Co., Ltd.

140410 Summary
Biopharma
Stock Price & Overview
₩65,000 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩65,000  ≈ US$46  ·  Market cap ₩2.0tn (≈ $1.4bn)

140410 Stock Price

50K100K150Kprev 65Kpeak 173KOctNovDecJan ’26FebMarAprMayJunJulAugSep65K
52 Week Range
₩50,100₩172,700
Day Range
₩62,900₩66,400
Market Cap
₩2.0tn
P/E (TTM)
n/a (loss)
P/B
50.98x
P/S (TTM)
236.15x
Volume
63,378
Shares Out
30.6M
Prev. Close
₩65,000
vs 52W High
-62.4%
Multiples use the close and the financials that were public on that date (DART), the same series as the Valuation tab — they are not vendor figures.

140410 Analysis

See all »

Nothing written yet for this company.

140410 News

See all »

No news written yet.

140410 Momentum

Period140410KOSDAQDifference
1 week-6.1%-3.0%-3.1%
1 month+19.5%+4.2%+15.3%
3 months+0.3%-22.5%+22.8%
6 months-43.8%-16.9%-27.0%
Year to date-27.9%-12.1%-15.8%
1 year+27.2%+1.0%+26.2%

Closed at 12% of the way from its 52-week low (₩50,100) to its 52-week high (₩172,700).

Price return on KRX closes, KOSDAQ on the same dates, no dividends. A period starts at the last trading day on or before the calendar date.

140410 Filings

See all »
DART

Half-Year Report

Periodic08/14/26title translated
DART

Insider / Major Shareholder Holdings Report ×3

Ownership08/06/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership07/28/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership07/21/26title translated
Korean issuers file to DART, not the SEC. Titles are translated; where kstock has read the filing the row carries the explanation.

140410 Company Profile

Mezzion Pharma Co., Ltd. does research and development in science and engineering in South Korea. It is listed on KOSDAQ, was founded in 2002, is based in Seoul, and has revenue of under ten billion won.

SectorBiopharmaEmployees
MarketKOSDAQFounded2002
Korean name메지온Head officeSeoul

Similar to 140410

SymbolLast Price
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
226950Olix Pharmaceuticals, Inc.₩95,900
+4.5%
068760Celltrion Pharm, Inc.₩40,850
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
039200Oscotec, Inc.₩36,600
+1.9%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.